Actualités RBC Core Bond Pool - RCOR | Actions NEO Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549...

Current Report Filing (8-k)

false 0001799850 0001799850 2022-09-22 2022-09-22 0001799850 rcor:CommonStockParValue0.0001PerShare2Member 2022-09-22 2022-09-22 0001799850...

Statement of Beneficial Ownership (sc 13d)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________ ...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-260299 Prospectus Supplement...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

Current Report Filing (8-k)

false 0001799850 0001799850 2022-09-19 2022-09-19 0001799850 us-gaap:CommonStockMember 2022-09-19 2022-09-19 0001799850...

Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

Acquisition further strengthens Rocket’s leadership in AAV-based cardiac gene therapy and expands Company’s near-term clinical assets for the...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-260299 Prospectus Supplement No. 11...

Quarterly Report (10-q)

0001799850false--12-31three yearsQ20001799850us-gaap:MeasurementInputExpectedTermMemberrcor:PrivatePlacementWa...

Current Report Filing (8-k)

0001799850false0001799850us-gaap:CommonStockMember2022-08-082022-08-0800017998502022-08-082022-08-080001799850us-gaap:WarrantMember2022-08-082022...

Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

REN-001 IND submission planned for the second half of 2022 Data from pilot pig study showing successful cardiac transduction with REN-001...

Current Report Filing (8-k)

false 0001799850 0001799850 2022-07-12 2022-07-12 0001799850 us-gaap:CommonStockMember 2022-07-12 2022-07-12 0001799850 us-gaap:WarrantMember...

Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy

Research collaboration with the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-260299 Prospectus Supplement No. 10 (to...

Amended Current Report Filing (8-k/a)

true00017998500001799850us-gaap:WarrantMember2022-05-302022-05-3000017998502022-05-302022-05-300001799850us-gaap:CommonStockMember2022-05-302022...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

RBC Core Bond Pool (RCOR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

RCOR Actualités

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Statement of Beneficial Ownership (sc 13d)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Quarterly Report (10-q)

Current Report Filing (8-k)

Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Current Report Filing (8-k)

Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Amended Current Report Filing (8-k/a)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

RBC Core Bond Pool (RCOR) Actualités

RBC Core Bond Pool (RCOR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

RCOR Actualités

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Statement of Beneficial Ownership (sc 13d)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Quarterly Report (10-q)

Current Report Filing (8-k)

Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Current Report Filing (8-k)

Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Amended Current Report Filing (8-k/a)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application